ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645665 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645665; 2) Community: the network communities that were significantly associated with the response to NSC 645665; 3) Molecule: the relationships between components within communities and NSC 645665; 4) MDR: the compounds that were significantly associated with the NSC 645665.

NSC Compound Enrichment Correlation
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0378615809326464 0.1877566
NSC 758465 SALINOMYCIN, SODIUM 0.0378615809326464 0.045730225
NSC 114512 Null 0.0385613993886001 0.19546789
NSC 117274 Null 0.0385613993886001 0.36509829
NSC 119875 Cisplatin 0.0385613993886001 0.14296738
NSC 138425 Kinamycin C 0.0385613993886001 0.27390073
NSC 139105 Soluble Baker's Antifol 0.0385613993886001 0.31544793
NSC 179187 Salasdine 0.0385613993886001 -0.0086486333
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0385613993886001 0.037334481
NSC 299117 24-Norchola-20,22-diene-4-carboxaldehyde, 3,12-bis(acetyloxy)-14,15:21,23-diepoxy-1,7,19-trihydroxy-4,8-dimethyl-11-oxo-, cyclic 4,19-(acetyl acetal), [1.alpha.,3.alpha.,4.beta.(S),5.alpha.,7.alpha., 0.0385613993886001 0.4817484
Total:81  Current:61    [First] [Prev] [Next] [Last]